Takeda's Debbie Ransby nominated for CFO Awards


Takeda Pharmaceuticals CFO Debbie Ransby has this year been nominated for a CFO Award for her efforts at the multinational over the past year. The annual 'Oscars for South African CFOs', to be held on 11 May, recognise CFOs of listed companies, large corporations, state-owned entities and government institutions, and awards them for outstanding performance and leadership.

Debbie was thrilled with her nomination and expressed her interest in networking opportunities provided by CFO South Africa:

"Networking and interacting with colleagues in what can be an incredibly challenging environment is vital. It is important to continue professional development and the learning process."

Chartered accountant Debbie began her career at PwC, where numerous dealings with clients like Pharmacare, Aspen and Ingelheim led her to pursue an interest in healthcare. She assumed a managerial position with GlaxoSmithKline, rising to Senior Finance Manager in her seven years with the pharmaceutical company, before joining Takeda (then Nycomed) as Finance Director in 2008. She has been heavily involved in the firm's African expansion and restructuring in Egypt and Algeria, as well as internal control initiatives, HR, marketing and compliance.

With a corporate history of more than 235 years, Takeda conducts pharmaceutical research activities to fourth its mission of ensuring "better health for people worldwide through leading innovation in medicine". The group network spans over 70 countries and regions worldwide, in Japan, the USA, Europe, Latin America, Africa, the Middle East and the Asia Pacific and its products are marketed in around 100 countries worldwide.

Related articles

Nominate your finance captain for the 2024 CFO Awards!

Nominations for the 2024 CFO Awards are now open. This is your chance to put forward the finance executives who have shown impeccable leadership over the last year, as they could walk away a winner at the annual Oscars of Finance!